Search

everythinglearnresearchcommunity

for

Search:↓

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Maintaining healthy mitochondria may help treat hair loss.

Plant extracts can help prevent hair loss and promote hair growth.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

The hedgehog signalling pathway is key in skin development and basal cell carcinoma, offering insights for prevention and treatment.

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

Sonic hedgehog signaling is crucial for hair growth and maintaining hair follicle identity.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

The Shh gene controls cell growth and death in cashmere goat hair follicles, affecting hair growth.

The method quickly analyzes hair growth genes and shows that blocking Smo in skin cells stops hair growth.

Hedgehog signaling in certain cells is crucial for hair growth during wound healing.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

GLI and EGF signalling affect Basal Cell Carcinoma development and could be therapeutic targets.

Mutations in the SHH pathway in certain skin cells can cause skin tumors and abnormal hair growth.

Huaier helps hair grow back and repairs tissue after cancer treatment.

Hedgehog signaling can create new hair follicles in adult skin but may increase cancer risk.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

Corporate social responsibility can improve consumer ratings of product performance, especially when the company is seen as benevolent and consumers aren't experts on the product.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.